Yu Sanada

Osaka, 5900494, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Development of polymer micelles comprising an alkenylboronic acid pinacol ester as boron agents for BNCT.

Development of polymer micelles comprising an alkenylboronic acid pinacol ester as boron agents for BNCT.

Journal: Journal of materials chemistry. B

Published: August 07, 2026

Transcriptome analysis of human oral squamous cancer SAS cells as an early response after boron neutron capture therapy.

Transcriptome analysis of human oral squamous cancer SAS cells as an early response after boron neutron capture therapy.

Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine

Published: September 30, 2024

HER-2-Targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging Reaction.

HER-2-Targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging Reaction.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: July 31, 2023

Correction: Imamichi et al. Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy. Biology 2022, 11, 420.

Correction: Imamichi et al. Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy. Biology 2022, 11, 420.

Journal: Biology

Published: July 19, 2023

Proteomic Characterization of SAS Cell-Derived Extracellular Vesicles in Relation to Both BPA and Neutron Irradiation Doses.

Proteomic Characterization of SAS Cell-Derived Extracellular Vesicles in Relation to Both BPA and Neutron Irradiation Doses.

Journal: Cells

Published: April 27, 2023

Phospholipid-Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy.

Phospholipid-Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy.

Journal: Chembiochem : a European journal of chemical biology

Published: March 08, 2023

HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex.

HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex.

Journal: Nanoscale advances

Published: January 13, 2023

Systems Biology Approach to Investigate Biomarkers, Boron-10 Carriers, and Mechanisms Useful for Improving Boron Neutron Capture Therapy.

Systems Biology Approach to Investigate Biomarkers, Boron-10 Carriers, and Mechanisms Useful for Improving Boron Neutron Capture Therapy.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: October 21, 2022

The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapy.

The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapy.

Journal: Journal of radiation research

Published: September 20, 2022

Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy.

Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy.

Journal: Journal of radiation research

Published: August 10, 2022

Carborane bearing pullulan nanogel-boron oxide nanoparticle hybrid for boron neutron capture therapy.

Carborane bearing pullulan nanogel-boron oxide nanoparticle hybrid for boron neutron capture therapy.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: April 19, 2022

Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy.

Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy.

Journal: Biology

Published: December 29, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026